Results 81 to 90 of about 271,809 (300)

Dyspnea perception in COPD: Association between anxiety, dyspnea-related fear and dyspnea in a pulmonary rehabilitation program

open access: yes, 2011
BACKGROUND: A growing body of research connects anxiety with poorer outcomes in COPD. However, more specific measures of dyspnea-related fear may be more closely related to critical processes involved in pulmonary rehabilitation (perception of dyspnea ...
Steven De Peuter   +13 more
core   +1 more source

Comparative Transcriptional Profiling of Key Macrophage and Fibroblast Subpopulations in Rheumatoid Arthritis–Associated Lung Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA) often involves extra‐articular complications, including interstitial lung disease (ILD) and/or pulmonary nodules. Transcriptomic profiling of lung tissue provides the opportunity to directly assess cell‐specific gene expression and corresponding pathway activation in different types of rheumatoid lung disease ...
Tracy Tabib   +8 more
wiley   +1 more source

Dyspnea catastrophizing and neural activations during the anticipation and perception of dyspnea

open access: yes, 2018
Dyspnea is an aversive symptom in various diseases. High levels of negative affectivity are typically associated with increased dyspnea and changes in its neural processing.
Esser, Roland W.   +4 more
core   +1 more source

Measures of dyspnea in pulmonary rehabilitation [PDF]

open access: yes, 2010
Dyspnea is the main symptom perceived by patients affected by chronic respiratory diseases. It derives from a complex interaction of signals arising in the central nervous system, which is connected through afferent pathway receptors to the peripheral ...
Clini Enrico M   +7 more
core   +1 more source

Expert Perspectives: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies

open access: yesArthritis &Rheumatology, EarlyView.
Treat‐to‐target has transformed the management of several rheumatic diseases through predefined therapeutic goals, structured disease assessment, and timely treatment adjustment. Despite major advances in the understanding and treatment of idiopathic inflammatory myopathies (IIM), a formal treat‐to‐target framework for adult IIM has not yet been ...
Shiri Keret   +2 more
wiley   +1 more source

FACIT Dyspnea (PROMIS Dyspnea)

open access: yes
Chronic Obstructive Pulmonary Disease (COPD) is the fourth major cause of death in the US with one of its major symptoms being dyspnea, or shortness of breath.
Yount, Susan
core   +1 more source

Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data.

open access: yesArthritis &Rheumatology, Accepted Article.
Background Little is known about the prevalence of and factors associated with Long COVID in patients with autoimmune rheumatic diseases (AIRDs). Methods We conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C).
Namrata Singh   +11 more
wiley   +1 more source

Dyspnea in pregnancy [PDF]

open access: yesJournal of Perinatal Medicine, 1975
COMROE et al. [1] define dyspnea in their book "The Lung" as a subjective Symptom only , sensed by the patient, the severity of which can only be gauged by the patient, as is true for other sensations. Dyspnea at rest occurs in 20% of pregnant women already in the 12th week of pregnancy.
openaire   +2 more sources

Obesity Impact on Dyspnea in COPD Patients [PDF]

open access: yes
Alexis Dupuis,1 Aurore Thierry,2 Jeanne-Marie Perotin,1,3 Julien Ancel,1,3 Valérian Dormoy,3 Sandra Dury,1 Gaëtan Deslée,1,3 Claire Launois1,3 1Department of Respiratory Diseases, University Hospital of Reims, Reims, France; 2Université de Reims ...
Launois C   +7 more
core  

Why does ticagrelor induce dyspnea?

open access: yes, 2012
In studies that compared the reversible P2Y12 inhibitor ticagrelor with the irreversible inhibitor clopidogrel, dyspnea was observed more frequently among ticagrelor-treated patients than among clopidogrel-treated patients.
M. Cattaneo, E.M. Faioni
core   +1 more source

Home - About - Disclaimer - Privacy